“Pfizer” announces that its trial of the “Corona” vaccine has not reached the stage of determining its effectiveness
Bloomberg News reported that, in a presentation including the results of the company’s third-quarter earnings, today (Tuesday), Pfizer said that the data control board made up of experts overseeing the experiment has not conducted a temporary efficacy analysis yet, according to German news agency DPA.
This means that less than 32 cases of infection with the “Corona” virus occurred among the participants in the experiment. The first of 4 efficacy tests will be conducted when the trial reaches this limit. Pfizer has registered more than 42,000 patients in its Corona vaccine trial. Today, Tuesday, the company said that about 36,000 people had received their second dose as of October 26. Given that it is one of the first competitors in the race to reach a vaccine for the “Corona” virus, the company “Pfizer” said that it may get initial effective results as soon as this month.
These were the details of the news “Pfizer” announces that its trial of the “Corona” vaccine has not... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
